Literature DB >> 15541046

Distribution of Entamoeba histolytica Gal/GalNAc lectin-specific antibody response in an endemic area.

U Kaur1, A K Sharma, M Sharma, H Vohra.   

Abstract

To demonstrate the dynamics of specific antibody isotypes against Entamoeba histolytica Gal/GalNAc adhesin and its correlation, if any, with the development of immunity, we evaluated subjects suffering from a spectrum of amoebic infections ranging from amoebic liver abscess (ALA) to asymptomatic cyst passers. The quantitative analysis of antibody levels was done in the sera by enzyme-linked immunosorbent assay. Gal/GalNAc adhesin-specific immunoglobulin G (IgG) was higher in ALA (and their follow-ups) and intestinal amoebiasis cases as compared with asymptomatic cyst passers (P < 0.05). Among the isotypes of IgG, high levels of IgG1 (60% of the total IgG concentration), suggestive of T-helper 2-type response, was associated with ALA cases. Intestinal amoebiasis cases and cyst passers had high percentage of IgG1 and IgG4 antibodies as compared with per cent IgG2 and IgG3 (of the total IgG), whereas follow-up cases of ALA had predominantly IgG2 and IgG3 isotypes of antibodies. Gal/GalNAc lectin-specific IgM antibodies were maximum in cases of intestinal amoebiasis. ALA cases and their follow-ups had significantly lower levels of Gal/GalNAc-specific IgM levels as compared with cyst passers (P < 0.05). Gal/GalNAc adhesin-specific IgA antibodies were raised maximally in intestinal amoebic infection cases. ALA cases and their 3-month follow-ups had significantly higher concentrations of lectin-specific IgA (P < 0.05) as compared with the healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541046     DOI: 10.1111/j.0300-9475.2004.01512.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

Review 1.  Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.

Authors:  Xiaoti Guo; Eric Houpt; William A Petri
Journal:  Curr Opin Immunol       Date:  2007-08-16       Impact factor: 7.486

Review 2.  The future for vaccine development against Entamoeba histolytica.

Authors:  Jeanie Quach; Joëlle St-Pierre; Kris Chadee
Journal:  Hum Vaccin Immunother       Date:  2014-02-06       Impact factor: 3.452

3.  Immune markers characteristic for asymptomatically infected and diseased Entamoeba histolytica individuals and their relation to sex.

Authors:  Hannah Bernin; Claudia Marggraff; Thomas Jacobs; Norbert Brattig; Van An Le; Jörg Blessmann; Hannelore Lotter
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

Review 4.  Immune Response of Amebiasis and Immune Evasion by Entamoeba histolytica.

Authors:  Kumiko Nakada-Tsukui; Tomoyoshi Nozaki
Journal:  Front Immunol       Date:  2016-05-12       Impact factor: 7.561

Review 5.  Immune Evasion Mechanisms of Entamoeba histolytica: Progression to Disease.

Authors:  Sharmin Begum; Jeanie Quach; Kris Chadee
Journal:  Front Microbiol       Date:  2015-12-15       Impact factor: 5.640

6.  Protection against Amoebic Liver Abscess in Hamster by Intramuscular Immunization with an Autographa californica Baculovirus Driving the Expression of the Gal-Lectin LC3 Fragment.

Authors:  Dulce María Meneses-Ruiz; Hugo Aguilar-Diaz; Raúl José Bobes; Alicia Sampieri; Luis Vaca; Juan Pedro Laclette; Julio César Carrero
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

7.  Evaluation of total immunoglobulin G and subclass antibodies in an enzyme-linked immunosorbent assay for serodiagnosis of human amebic liver abscess.

Authors:  Penchom Janwan; Lakkhana Sadaow; Rutchanee Rodpai; Hiroshi Yamasaki; Vor Luvira; Wattana Sukeepaisarnjaroen; Amnat Kitkhuandee; Krisada Paonariang; Oranuch Sanpool; Patcharaporn Boonroumkaew; Tongjit Thanchomnang; Toshihiro Mita; Pewpan M Intapan; Wanchai Maleewong
Journal:  PeerJ       Date:  2022-09-29       Impact factor: 3.061

8.  Evaluation of Entamoeba histolytica recombinant phosphoglucomutase protein for serodiagnosis of amoebic liver abscess.

Authors:  Tan Zi Ning; Wong Weng Kin; Rahmah Noordin; See Too Wei Cun; Foo Phiaw Chong; Zeehaida Mohamed; Alfonso Olivos-Garcia; Lim Boon Huat
Journal:  BMC Infect Dis       Date:  2013-03-21       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.